Tumor marker tests revealed markedly elevated levels of carcinoembryonic antigen (CEA) 39 019.9 ng/mL, NSE 296.5 ng/mL, and CA19‐9 > 100 000 U/mL. This evidence concerns the gene CEACAM5 and neoplasm.